4//SEC Filing
Prener Anne 4
Accession 0000899243-20-010048
CIK 0001751299other
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 8:57 AM ET
Size
5.5 KB
Accession
0000899243-20-010048
Insider Transaction Report
Form 4
Prener Anne
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-04-01+30,000→ 30,000 totalExercise: $5.21Exp: 2030-04-01→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]Thirty three percent of this option shall vest on April 1, 2021, with the remainder vesting in two equal annual installments thereafter, subject to Dr. Prener's continued service on the board of directors through each such date. This grant was made in accordance with the Company's Non-Employee Director Compensation Policy.
Documents
Issuer
Kaleido Biosciences, Inc.
CIK 0001751299
Entity typeother
Related Parties
1- filerCIK 0001797917
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 8:57 AM ET
- Size
- 5.5 KB